India's Hospital-Backed Pharmacy That Puts Accuracy First Exact Brand. Exact Strength. Genuine Medicines. No Hidden Substitutions. |
Offer Coming Soon
Support: 0824 2880 880 | 100% Secure Checkout
Brilinta 90mg Tablet
Brilinta 90mg Tablet
Indiana Verified Parameters SKU: N/A
Pay on Delivery Available
Return Policy 7 Days Returnable
Expiry Tracked Enforced
Item Sourcing 100% Genuine
Cardiology Prescription Mandate

Brilinta 90mg Tablet

90mg Tablet

Brand / Label: AstraZeneca

₹609.00
Availability Status: In Stock
Generic Composition Ticagrelor (90mg)
Packaging Metrics 14 strip (14 units / pack)
Administration Route Oral
Regulatory Schedule Prescription Required (Schedul
Quick Clinical Insights Summary

Brilinta 90mg Tablet contains Ticagrelor 90 mg, an antiplatelet medicine used to reduce the risk of heart attack, stroke, and cardiovascular death in patients with acute coronary syndrome (ACS), previous myocardial infarction (heart attack), or after coronary stent placement. It helps prevent blood clots by reducing platelet aggregation and is commonly prescribed together with low-dose aspirin unless otherwise directed by the treating physician.

Common Treatment Indications

Prevention of heart attack (Myocardial Infarction) Prevention of ischemic stroke Acute Coronary Syndrome (ACS) Unstable Angina After Coronary Angioplasty (PCI/PTCA) Prevention of stent thrombosis

Standard Clinical Dosage Guideline

Take exactly as prescribed by your doctor.
Swallow the tablet whole with water.
Can be taken with or without food.
Usually prescribed together with low-dose aspirin.
Do not discontinue treatment without medical advice, as this may increase the risk of serious cardiovascular events.

Comprehensive Product Overview
Brilinta 90mg Tablet contains Ticagrelor 90 mg, an antiplatelet medicine used to reduce the risk of heart attack, stroke, and cardiovascular death in patients with acute coronary syndrome (ACS), previous myocardial infarction (heart attack), or after coronary stent placement. It helps prevent blood clots by reducing platelet aggregation and is commonly prescribed together with low-dose aspirin unless otherwise directed by the treating physician.
Critical Safety Interoperability & Contraindications
General Warnings

No general physiological alerts logged.

Contraindications

None explicitly declared.

Drug-Drug Interactions

Standard verification parameters match.

Side Effects Profile

Common: Negglygible side effects registered.

Dietary/Food Matrix Constraints

No specific nutritional constraints recorded.


Physiological Adjustments & Cohort Profiling
Pregnancy Lactation Pediatric Cohorts Geriatric Cohorts
Consult your practitioner. Consult your practitioner. Standard safety indices apply. Standard dose matching applies.

Alcohol Constraints

No unique safety flags logged.

Kidney Impairment Context

Standard renal clearance indices.

Liver Impairment Context

Standard hepatic metabolism indices.

Patient Feedback & Verified Reviews

No patient evaluation data has been logged for this metric yet.

Related Healthcare Formulations